Crescent Capital BDC, Inc. (NASDAQ:CCAP) Given Consensus Rating of “Hold” by Brokerages

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have been given an average recommendation of “Hold” by the six ratings firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $13.90.

A number of brokerages recently commented on CCAP. B. Riley Financial restated a “neutral” rating on shares of Crescent Capital BDC in a research note on Friday, May 15th. Wall Street Zen upgraded shares of Crescent Capital BDC from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. Keefe, Bruyette & Woods lowered their price target on shares of Crescent Capital BDC from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Tuesday, June 16th. Wells Fargo & Company dropped their price objective on shares of Crescent Capital BDC from $13.00 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, May 15th. Finally, LADENBURG THALM/SH SH reduced their price objective on shares of Crescent Capital BDC from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, May 15th.

Insider Transactions at Crescent Capital BDC

In related news, CEO Jason Breaux acquired 5,000 shares of the firm’s stock in a transaction on Wednesday, May 20th. The shares were bought at an average cost of $11.19 per share, with a total value of $55,950.00. Following the completion of the acquisition, the chief executive officer owned 52,636 shares of the company’s stock, valued at $588,996.84. This trade represents a 10.50% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Henry Chung acquired 4,500 shares of the stock in a transaction dated Thursday, May 21st. The stock was bought at an average price of $11.45 per share, for a total transaction of $51,525.00. Following the completion of the purchase, the president owned 20,722 shares in the company, valued at approximately $237,266.90. This trade represents a 27.74% increase in their position. The disclosure for this purchase is available in the SEC filing. 1.23% of the stock is owned by company insiders.

Institutional Trading of Crescent Capital BDC

Several institutional investors have recently bought and sold shares of CCAP. Northwestern Mutual Wealth Management Co. acquired a new position in Crescent Capital BDC during the fourth quarter worth $27,000. Rockefeller Capital Management L.P. acquired a new stake in shares of Crescent Capital BDC in the 4th quarter valued at $35,000. VPR Management LLC grew its holdings in shares of Crescent Capital BDC by 150.0% in the 3rd quarter. VPR Management LLC now owns 5,000 shares of the company’s stock worth $71,000 after purchasing an additional 3,000 shares during the last quarter. Beaumont Financial Advisors LLC bought a new stake in shares of Crescent Capital BDC in the 1st quarter worth about $127,000. Finally, Permanens Capital L.P. bought a new stake in shares of Crescent Capital BDC in the 3rd quarter worth about $147,000. Institutional investors and hedge funds own 49.46% of the company’s stock.

Crescent Capital BDC Trading Down 1.3%

Crescent Capital BDC stock opened at $11.05 on Friday. Crescent Capital BDC has a 52 week low of $10.77 and a 52 week high of $16.03. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.53 and a current ratio of 1.53. The firm has a market capitalization of $407.15 million, a PE ratio of 26.95 and a beta of 0.52. The business’s 50-day simple moving average is $11.34 and its 200-day simple moving average is $12.78.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, May 13th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Crescent Capital BDC had a net margin of 9.26% and a return on equity of 9.34%. The business had revenue of ($6.83) million for the quarter, compared to analyst estimates of $39.58 million. Equities research analysts forecast that Crescent Capital BDC will post 1.38 earnings per share for the current year.

Crescent Capital BDC Dividend Announcement

The firm also recently declared a special dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be given a $0.03 dividend. This represents a yield of 107.0%. The ex-dividend date of this dividend is Monday, November 30th. Crescent Capital BDC’s dividend payout ratio is 331.71%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.